Sangui Biotech International Inc - ESG Rating & Company Profile powered by AI
Jump to the end of the page for potential risks for Sangui Biotech International Inc based on industry, location and size. This analysis of Sangui Biotech International Inc leverages information from across the web as well as from public filings by Sangui Biotech International Inc. This webpage of Sangui Biotech International Inc is prepared by All Street Sevva using leading Cognitive Robots.
Sangui Biotech International Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 4.0, social score of 5.3 and governance score of 8.0.
5.8
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
521 | Smruthi Organics Ltd | 5.9 | High |
521 | Vectura Group PLC | 5.9 | High |
541 | Sangui Biotech International Inc | 5.8 | High |
541 | Cantargia AB | 5.8 | High |
541 | Amplia Therapeutics Ltd | 5.8 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Sangui Biotech International Inc have an accelerator or VC vehicle to help deliver innovation?
Does Sangui Biotech International Inc disclose current and historical energy intensity?
Does Sangui Biotech International Inc report the average age of the workforce?
Does Sangui Biotech International Inc reference operational or capital allocation in relation to climate change?
Does Sangui Biotech International Inc disclose its ethnicity pay gap?
Does Sangui Biotech International Inc disclose cybersecurity risks?
Does Sangui Biotech International Inc offer flexible work?
Does Sangui Biotech International Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Sangui Biotech International Inc disclose the number of employees in R&D functions?
Does Sangui Biotech International Inc conduct supply chain audits?
Does Sangui Biotech International Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Sangui Biotech International Inc conduct 360 degree staff reviews?
Does Sangui Biotech International Inc disclose the individual responsible for D&I?
Does Sangui Biotech International Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Sangui Biotech International Inc disclose current and / or historical scope 2 emissions?
Does Sangui Biotech International Inc disclose water use targets?
Does Sangui Biotech International Inc have careers partnerships with academic institutions?
Did Sangui Biotech International Inc have a product recall in the last two years?
Does Sangui Biotech International Inc disclose incidents of discrimination?
Does Sangui Biotech International Inc allow for Work Councils/Collective Agreements to be formed?
Has Sangui Biotech International Inc issued a profit warning in the past 24 months?
Does Sangui Biotech International Inc disclose parental leave metrics?
Does Sangui Biotech International Inc disclose climate scenario or pathway analysis?
Does Sangui Biotech International Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Sangui Biotech International Inc disclose the pay ratio of women to men?
Does Sangui Biotech International Inc support suppliers with sustainability related research and development?
Does Sangui Biotech International Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Sangui Biotech International Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Sangui Biotech International Inc involved in embryonic stem cell research?
Does Sangui Biotech International Inc disclose GHG and Air Emissions intensity?
Does Sangui Biotech International Inc disclose its waste policy?
Does Sangui Biotech International Inc report according to TCFD requirements?
Does Sangui Biotech International Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Sangui Biotech International Inc disclose energy use targets?
Does Sangui Biotech International Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Sangui Biotech International Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Sangui Biotech International Inc
These potential risks are based on the size, segment and geographies of the company.
Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray under the Granulox brand. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.